PresentaciÃ³n Su elaboraciÃ³n en formato electrÃ³nico, iniciada en ...

More documents

Recommendations

Info

• LUNA MALDONADO A. (2003). APROXIMACIÓN TOXICOLÓGICA A LOSPSICOESTIMULANTES UTILIZADOS CON FINES RECREATIVOS. Adicciones. v. 15; sup.2; p. 97-109.DGPNSD• MCCANN U.D., RICAURTE G.A. (2003). NEUROIMAGEN Y NEUROTOXIDIDADINDUCIDA POR MDMA (ÉXTASIS). Adicciones. v. 15; sup. 2; p. 111-120.DGPNSD• MCLEAN S., RICHMOND R., LOPATKO O., SAUNDERS J., YOUNG R. (2002).TOBACCO. EN: MANAGEMENT OF ALCOHOL AND DRUG PROBLEMS. NEW YORK:OXFORD UNIVERSITY. p. 100-123.R-5261• PÉREZ RIAL S., ORTIZ S., MANZANARES J. (2003). NEUROBIOLOGÍA DE LADEPENDENCIA ALCOHÓLICA. Trastornos Adictivos. v. 5; nº 1; p. 4-12.DGPNSD• RAMAEKERS J.G., BERGHAUS G., LAAR M. VAN., DRUMMER O.H. (2003).PERFORMANCE IMPAIRMENT AND RISK OF MOTOR VEHICLE CRASHES AFTERCANNABIS USE. EN: CANNABIS 2002 REPORT : A JOINT INTERNATIONAL EFFORTAT THE INITIATIVE OF THE MINISTERS OF PUBLIC HEALTH OF BELGIUM, FRANCE,GERMANY, THE NETHERLANDS AND SWITZERLAND.- BRUSSELS: MINISTRY OFPUBLIC HEALTH. h. 79-95.R-5269• RAMOS ATANCE J. A., FERNÁNDEZ RUIZ J. (2003). MECANISMOS NEUROQUÍMICOSDE LA DROGODEPENDENCIA. DROGODEPENDENCIAS: FARMACOLOGÍA.PATOLOGÍA. PSICOLOGÍA. LEGISLACIÓN. MADRID: MEDICA PANAMERICANA. p. 57-68.R-5183• SAUNDERS J., YOUNG R., HULSE G., MCLEAN S., MARTIN J., ROBINSON G. (2002).OPIOIDS. EN: MANAGEMENT OF ALCOHOL AND DRUG PROBLEMS: NEW YORK:OXFORD UNIVERSITY. P. 79-99.R-5261• SCHENK J.O. (2002). FUNCTIONING NEURONAL TRANSPORTER FOR DOPAMINE:KINETIC MECHANISMS AND EFFECTS OF AMPHETAMINES, COCAINE AND ME.Progress Drug Res. v. 59; p. 111-131.02-204• SOLE PUIG J., RAMOS ANTANCE J.A. (2001). CANNABINOIDES : ASPECTOSPSIQUIÁTRICOS Y BIOQUÍMICOS. BARCELONA: ROL. 237 p.R-5268• STREEL E., VERBANCK P., PELC I. (2003). PHARMACOLOGY AND NEUROBIOLOGYOF CANNABIS. EN: CANNABIS 2002 REPORT : A JOINT INTERNATIONAL EFFORT ATTHE INITIATIVE OF THE MINISTERS OF PUBLIC HEALTH OF BELGIUM, FRANCE,GERMANY, THE NETHERLANDS AND SWITZERLAND.- BRUSSELS: MINISTRY OFPUBLIC HEALTH. h. 46-53.R-5269• TODD F., LCLEAN S., KRUM H., MARTIN J., COPELAND J. (2002). CANNABIS. EN:MANAGEMENT OF ALCOHOL AND DRUG PROBLEMS. NEW YORK: OXFORDUNIVERSITY. p. 141-157.R-5261• WHITE J., MARTIN J., KRUM H., MCLEAN S., YOUNG R., SAUNDERS J. (2002).HALLUCINOGENS. EN: MANAGEMENT OF ALCOHOL AND DRUG PROBLEMS. NEWYORK: OXFORD UNIVERSITY. p. 229-238.R-526110
Efectos y consecu<strong>en</strong>cias• ALVAREZ SALA WALTHER J. L., MARTÍNEZ CRUZ R., CALLE RUBIO M. TABAQUISMOPASIVO. (2003). EN: DROGODEPENDENCIAS: FARMACOLOGÍA. PATOLOGÍA.PSICOLOGÍA. LEGISLACIÓN. MADRID: MÉDICA PANAMERICANA. p. 493-502.R-5183• BERGERET I., PAPAGEORGIOU C., VERBANCK P., PELC I. (2003). CANNABIS ANDPSYSICAL HEALTH. EN: CANNABIS 2002 REPORT : A JOINT INTERNATIONALEFFORT AT THE INITIATIVE OF THE MINISTERS OF PUBLIC HEALTH OF BELGIUM,FRANCE, GERMANY, THE NETHERLANDS AND SWITZERLAND.- BRUSSELS:MINISTRY OF PUBLIC HEALTH. h. 55-61.R-5269• BOBES GARCÍA J., SAIZ MARTÍNEZ P. A. (2003). DROGAS DE DISEÑO III :COMPLICACIONES PSIQUIÁTRICAS DEL USO DE DROGAS DE DISEÑO (MDMA). EN:DROGODEPENDENCIAS : FARMACOLOGIA PATOLOGIA PSICOLOGIA LEGISLACION.-MADRID: MEDICA PANAMERICANA. p. 247-254.R-5183• BUDNEY A. J., MOORE B. A., VANDREY R.G., HUGHES J. R. (2003). TIME COURSEAND SIGNIFICANCE OF CANNABIS WITHDRAWAL. J Abnormal Psychol. V. 112 ; n. 3 ; p.393-402.08-586• CAPE G., HULSE G., ROBINSON G., MCLEAN S., SAUNDERS J., YOUNG R., MARTIN J.(2002). SEDATIVE-HIPNOTICS. EN: MANAGEMENT OF ALCOHOL AND DRUGPROBLEMS.- NEW YORK: OXFORD UNIVERSITY. p. 212-228.R-5261• CAZALETS C., LAURAT E., CADOR B., JAN F., ROLLAND Y., JEGO P., GROSBOIS B.(2003). ARTERIOPATHIES DU CANNABIS : QUATRE NOUVEAUX CAS CANNABISARTERITIS : FOUR NEW CASES. Rev Med Int. v. 24; p. 127-130.08-584• DORE G. (2002). WOMEN AND SUBSTANCE ABUSE. EN: MANAGEMENT OFALCOHOL AND DRUG PROBLEMS.- NEW YORK: OXFORD UNIVERSITY. p. 289-310.R-5261• GERGUSSON D. M., HORWOOD L. J., SWAIN CAMBELL N. R. (2003). CANNABISDEPENDENCE AND PSYCHOTIC SYMPTOMS IN YOUNG PEOPLE. Psychol Med. v. 33;p. 15-21.08-588• FREIXA F. (2003). ALCOHOL Y VHC. Rev Esp Drogodep<strong>en</strong>d. v. 28; n. 3; p. 250-257.DGPNDSD• HALL W., LICCARDO PACULA R. (2003). HEALTH EFFECTS OF CANNABIS. EN:CANNABIS USE AND DEPENDENCE : PUBLIC HEALTH AND PUBLIC POLICY.-CAMBRIDGE: CAMBRIDGE UNIVERSITY PRESS. p. 31-65.R-5233• HALL W., LICCARDO PACULA R. (2003). PSYCHOLOGICAL EFFECTS OF CHRONICCANNABIS USE. EN: CANNABIS USE AND DEPENDENCE : PUBLIC HEALTH ANDPUBLIC POLICY.- CAMBRIDGE: CAMBRIDGE UNIVERSITY PRESS. p. 67-99.R-5233• HALL W. LICCARDO PACULA R. (2003). COMPARING THE HEALTH EFFECTS OFCANNABIS WITH ALCOHOL AND TOBACCO. EN: CANNABIS USE AND DEPENDENCE:PUBLIC HEALTH AND PUBLIC POLICY.- CAMBRIDGE: CAMBRIDGE UNIVERSITYPRESS. p. 130-141.R-523311
Page 1 and 2: PresentaciónSu elaboración en for
Page 6 and 7: • FUENTES GONZALEZ G. (2003). PRO
Page 8 and 9: • SAUNDERS J., YOUNG R. (2002). A
Page 12 and 13: • HANAK C., TECCO J., VERBANCK P.
Page 14 and 15: • MARTÍNEZ GONZÁLEZ J.M. (2003)
Page 16 and 17: • COMAS ARNAU D.; coord. AGUINAGA
Page 18 and 19: • RANZETTA L., FITZPTRICK J., SEL
Page 20 and 21: • CASTELLO NICAS N. (2003). EXENC
Page 22 and 23: • LUNA JIMENEZ DE PARGA P., GALLA
Page 24 and 25: • VALLS PRIETO J. (2003). LEGISLA
Page 26: • KUHN C., SWARTZWELDER S., WILSO
Page 29 and 30: • NATIONAL INSTITUTE ON DRUG ABUS
Page 31 and 32: • BRAVO D. (2001). UNIDAD MOVIL D
Page 33 and 34: • GOLTZMAN P., CYMERMAN P., ROSSI
Page 35 and 36: • RADULICH G.C., VIVAS L.E., BRUN
Page 37 and 38: • VITORIA ISUSI A.; coord., ALVAR
Page 39 and 40: • JIMENEZ M., MONASOR R.,RUBIO VA
Page 41 and 42: • CALAFAT FAR A., JUAN M. (2003).
Page 43 and 44: • SASOIA. EDUCACION PARA LA SALUD
Page 45 and 46: • LADERO QUESADA J.M., MARTIN DEL
Page 47 and 48: • LADERO QUESADA J.M., MARTIN DEL
Page 49 and 50: • JOHANSSON B.A. (2003). PHARMACO
Page 51 and 52: • ESPAÑA. MINISTERIO DE SANIDAD
Page 53 and 54: • ANDALUCIA (COMUNIDAD AUTONOMA).
Page 55 and 56: • JENSEN E.L. (2003). SANCIONES N
Page 57 and 58: • NACIONES UNIDAS. PROGRAMA MUNDI
Page 59 and 60: • ESPAÑA. PLAN NACIONAL SOBRE DR
Page 61 and 62:
BOE 16/12/2003MINISTERIO DEL INTERI
Page 63 and 64:
BOE 19/12/2003COMUNIDAD AUTÓNOMA D
Page 65 and 66:
Addiction .........................
Page 67 and 68:
AddictionVOLUME 98 • SUPPLEMENT 2
Page 69 and 70:
………….ADDICTIVE BEHAVIORSAN
Page 71 and 72:
ADDICTIVE BEHAVIORSAN INTERNATIONAL
Page 73 and 74:
ADDICTIVE BEHAVIORSAN INTERNATIONAL
Page 75 and 76:
adicciones Monografía Drogas recre
Page 77 and 78:
THE AMERICAN JOURNAL OF DRUG AND AL
Page 79 and 80:
CDD DDZCentro de Documentaciónde d
Page 81 and 82:
CDD DDZCentro de Documentaciónde d
Page 83 and 84:
DRUG andALCOHOLDEPENDENCEVolume 72,
Page 85 and 86:
DRUG andALCOHOLDEPENDENCEVolume 73,
Page 87 and 88:
IDEA prevenciónnº 27 julio/diciem
Page 89 and 90:
Volume 22 Number 3 2003CONTENTSEDIT
Page 91 and 92:
Buprenorphine for Opiate Dependence
Page 93 and 94:
Circuit Parties and Patterns of Dru
Page 95 and 96:
963 Towards an HIV Role Theory: Dru
Page 97 and 98:
Drug Use Among Texas Alternative Sc
Page 99 and 100:
Contents (continued)GOLDSTEIN, A.L.
Page 101 and 102:
Journal of Substance Abuse Treatmen
Page 103 and 104:
Journal of Substance Abuse Treatmen
Page 105 and 106:
PSYCHOLOGY OFADDICTIVE BEHAVIORSVol
Page 107 and 108:
PUBLIC HEALTH ReportVOLUME 118 NUMB
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
REVISTA DE ESTUDIOS DE JUVENTUDNº
Page 115 and 116:
RTS - REVISTA DE TREBALL SOCIALNúm
Page 117 and 118:
Contents ContinuedRESEARCH NOTESCli
Page 119 and 120:
TOBACCO CONTROLDecember 2003Vol. 12
Page 121:
trastornosadictivosVolumen 6 • N
show all

PresentaciÃ³n Su elaboraciÃ³n en formato electrÃ³nico, iniciada en ...

Create successful ePaper yourself

Delete template?

Save as template?